Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › telmisartan

telmisartan

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of telmisartan

18 trials tracked of telmisartan: 11 in phase 3 or 4 and 2 with published results. The most-cited published study has 28 citations.

18Trials tracked
11Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 6 Phase 3 5 Phase 2 3 Phase 1 1 Other / NA 3
  1. Phase 4 Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia Completed · 28 cited
  2. Phase 4 A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R Completed · 20 cited
  3. Phase 4 INTERVENCION Trial Completed
  4. Phase 4 Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension Completed
  5. Phase 4 Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal Completed
  6. Phase 4 Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. Completed
Show 12 more trials
  1. Phase 3 Telmisartan 80mg Non-responder Trial Completed
  2. Phase 3 HALT Progression of Polycystic Kidney Disease Study B Completed
  3. Phase 3 HALT Progression of Polycystic Kidney Disease Study A Completed
  4. Phase 3 Filtered Trial for Telmisartan 40mg Non-responder Completed
  5. Phase 3 Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension Completed
  6. Phase 2 A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease Completed
  7. Phase 2 HIV and Fat Accumulation Completed
  8. Phase 2 Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) Completed
  9. Phase 1 Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use Completed
  10. N/A Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension Completed
  11. N/A J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation Completed
  12. N/A Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease Completed

Showing the 18 most-cited and recently-updated of 18 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Telmisartan leads to modest fasting blood sugar reduction in patients with MASLD
Gastroenterology Meta-analysis
Telmisartan leads to modest fasting blood sugar reduction in patients with MASLD Telmisartan Shows Modest Effects on Blood Sugar in Liver Disease
This meta-analysis of 258 adults with MASLD found that telmisartan resulted in a modest reduction in fasting blood sugar of -2.78 mg/dL. Oth…
A review of clinical data suggests that the medication telmisartan may lower fasting blood sugar in adults with certain types of liver disea…
Sep 1, 2026
Triple Pill Therapy Lowers Recurrent Stroke Incidence in Patients With Prior Intracerebral Hemorrhage
Neurology RCT
Triple Pill Therapy Lowers Recurrent Stroke Incidence in Patients With Prior Intracerebral Hemorrhage Single pill with three blood pressure drugs cuts stroke risk after brain bleed
This multinational randomized controlled trial enrolled 1670 patients with a history of intracerebral hemorrhage and baseline systolic blood…
A single pill combining three low-dose blood pressure drugs reduced recurrent stroke risk by 39% in people who had a brain bleed.
Jun 4, 2026